We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » IMAGING FIRM WARNED FOR GMP, MANAGEMENT CONTROL FAILURES
The item has been added to your shopping cart.
IMAGING FIRM WARNED FOR GMP, MANAGEMENT CONTROL FAILURES
March 12, 2004
The FDA has issued a warning letter to Dublin, Calif.-based Obsidian Medical Technology for allegedly violating numerous good manufacturing practice requirements of the quality system regulation (QSR).